Your browser doesn't support javascript.
loading
Decreased risk of treatment failure with vedolizumab and thiopurines combined compared with vedolizumab monotherapy in Crohn's disease.
Kirchgesner, Julien; Desai, Rishi J; Schneeweiss, Maria C; Beaugerie, Laurent; Schneeweiss, Sebastian; Kim, Seoyoung C.
Afiliação
  • Kirchgesner J; Gastroenterology, AP-HP, Hôpital Saint-Antoine, Paris, France julien.kirchgesner@gmx.com.
  • Desai RJ; Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, France.
  • Schneeweiss MC; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Beaugerie L; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Schneeweiss S; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Kim SC; Gastroenterology, AP-HP, Hôpital Saint-Antoine, Paris, France.
Gut ; 71(9): 1781-1789, 2022 09.
Article em En | MEDLINE | ID: mdl-35387877
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Colite Ulcerativa / Doença de Crohn Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Colite Ulcerativa / Doença de Crohn Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article